Sign Out
As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event following the administration of the vaccine.
As with other intramuscular injection, patients with bleeding disorder such as hemophilia and thrombocytopenia or patients on anticoagulant therapy should not receive SKYCellflu Quadrivalent unless the potential benefit outweighs the risk of administration. If the decision is made to administer SKYCellflu Quadrivalent in such persons, it should be administered with caution to avoid the risk of hematoma formation following injection.
Effects on ability to drive and use machines: The vaccine is unlikely to produce an effect on the ability to drive and use machines.
